CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Jaguar Health, Inc. - JAGX CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 0.73-61.13
Average Volume (10 days) 3.35M
Average Volume (3 months) 20.93M
Market Cap 1.57M
P/E Ratio -100.00K
Shares Outstanding 4.03M
Revenue 10.78M
EPS -58.95
Dividend (Yield %) N/A
Beta 1.97
Next Earnings Date Mar 24, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Jaguar Health, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 4.335 9.385 5.77526 4.41615 4.36119
Revenue 4.335 9.385 5.77526 4.41615 4.36119
Cost of Revenue, Total 2.333 3.28 3.81581 2.76575 0.88041
Gross Profit 2.002 6.105 1.95945 1.6504 3.48078
Total Operating Expense 45.796 37.896 39.6643 34.5802 39.0853
Selling/General/Admin. Expenses, Total 25.997 20.996 20.4389 22.1088 14.3314
Research & Development 15.079 6.413 5.81982 5.15475 4.26946
Unusual Expense (Income) 2.387 7.207 9.58971 4.55093 19.604
Operating Income -41.461 -28.511 -33.889 -30.1641 -34.7241
Interest Income (Expense), Net Non-Operating -10.374 -5.488 -4.72125 -2.29767 -0.51429
Other, Net -0.765 0.19 0.08083 0.31569 0.08855
Net Income Before Taxes -52.6 -33.809 -38.5294 -32.1461 -35.1499
Net Income After Taxes -52.6 -33.809 -38.5394 -32.1461 -21.9686
Net Income Before Extra. Items -52.595 -33.809 -38.5394 -32.1461 -21.9686
Net Income -52.595 -33.809 -38.5394 -32.1461 -21.9686
Total Adjustments to Net Income 0 -4.839 -6.18681
Income Available to Common Excl. Extra. Items -52.595 -38.648 -44.7262 -32.1461 -21.9686
Income Available to Common Incl. Extra. Items -52.595 -38.648 -44.7262 -32.1461 -21.9686
Diluted Net Income -52.595 -38.648 -44.7262 -32.1461 -21.9686
Diluted Weighted Average Shares 44.7116 12.8807 1.6551 0.06991 0.96523
Diluted EPS Excluding Extraordinary Items -1.17632 -3.00045 -27.0234 -459.827 -22.7599
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -1.12293 -2.44093 -23.2572 -394.729 -9.55829
Total Extraordinary Items 0
Minority Interest 0.005
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 2.625 2.08 0.63 0.385 1.241
Revenue 2.625 2.08 0.63 0.385 1.241
Cost of Revenue, Total 0.455 0.469 0.617 0.664 0.583
Gross Profit 2.17 1.611 0.013 -0.279 0.658
Total Operating Expense 17.194 12.902 10.159 11.965 10.76
Selling/General/Admin. Expenses, Total 8.979 6.951 6.23 7.259 5.548
Research & Development 4.945 5.482 3.312 3.87 2.414
Unusual Expense (Income) 2.815 0 0 0.172 2.215
Operating Income -14.569 -10.822 -9.529 -11.58 -9.519
Interest Income (Expense), Net Non-Operating -4.427 -2.747 -2.643 -2.484 -2.5
Other, Net 0.832 -0.749 -0.02 -0.017 0.01
Net Income Before Taxes -18.164 -14.318 -12.192 -14.081 -12.009
Net Income After Taxes -18.164 -14.318 -12.192 -14.081 -12.009
Net Income Before Extra. Items -17.986 -14.313 -12.192 -14.081 -12.009
Net Income -17.986 -14.313 -12.192 -14.081 -12.009
Total Adjustments to Net Income 0 0 0 0
Income Available to Common Excl. Extra. Items -17.986 -14.313 -12.192 -14.081 -12.009
Income Available to Common Incl. Extra. Items -17.986 -14.313 -12.192 -14.081 -12.009
Diluted Net Income -17.986 -14.313 -12.192 -14.081 -12.009
Diluted Weighted Average Shares 44.7116 46.3427 45.8403 44.8117 41.805
Diluted EPS Excluding Extraordinary Items -0.40227 -0.30885 -0.26597 -0.31423 -0.28726
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.33931 -0.30885 -0.26597 -0.31039 -0.23428
Minority Interest 0.178 0.005
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 28.434 17.792 9.52235 8.14994 3.7991
Cash and Short Term Investments 17.051 8.09 3.49543 2.56819 0.5207
Cash & Equivalents 0.5207
Total Receivables, Net 2.144 4.56 1.69458 1.0018 0.46904
Accounts Receivable - Trade, Net 1.709 4.532 1.69171 0.99568 0.46766
Total Inventory 4.9 2.782 2.12869 3.34218 2.07282
Prepaid Expenses 4.339 2.36 1.26274 1.23777 0.49737
Other Current Assets, Total 0 0.94091 0 0.23917
Total Assets 53.265 42.843 36.4104 41.042 43.6292
Property/Plant/Equipment, Total - Net 1.734 0.677 0.71021 0.76062 1.22207
Other Long Term Assets, Total 0.446 0.037 0.15397 0.42083 0
Total Current Liabilities 15.471 13.22 15.3924 26.6588 15.3858
Accounts Payable 4.929 4.759 5.35154 5.41426 7.35493
Accrued Expenses 7.357 4.493 3.2589 4.93944 2.19955
Notes Payable/Short Term Debt 0 0 0 4.84558 1.14115
Current Port. of LT Debt/Capital Leases 3.184 3.789 6.77846 11.2392 4.28146
Other Current Liabilities, Total 0.001 0.179 0.00349 0.22038 0.40867
Total Liabilities 41.654 25.641 15.8424 26.6588 26.3682
Total Long Term Debt 25.022 12.421 0.45 0 10.9824
Long Term Debt 25.022 12.421 0.45 0 10.9824
Other Liabilities, Total 0.919 0
Total Equity 11.611 17.202 20.568 14.3831 17.261
Redeemable Preferred Stock 0 0 11.6065 9 0
Common Stock 0.005 0.011 0.00546 0.00649 0.01053
Additional Paid-In Capital 231.1 184.09 142.046 99.9274 79.6552
Retained Earnings (Accumulated Deficit) -219.494 -166.899 -133.09 -94.5508 -62.4047
Total Liabilities & Shareholders’ Equity 53.265 42.843 36.4104 41.042 43.6292
Total Common Shares Outstanding 50.4733 40.1279 45.0589 40.4184 42.6378
Goodwill, Net 0 5.21082
Intangibles, Net 22.651 24.337 26.0239 31.7106 33.3972
Cash 17.051 8.09 3.49543 2.56819
Property/Plant/Equipment, Total - Gross 2.032 0.942 0.93428
Accumulated Depreciation, Total -0.298 -0.265 -0.22407
Total Preferred Shares Outstanding 0 0 5.53706
Minority Interest 0.242
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 28.474 28.434 24.005 44.294 44.104
Cash and Short Term Investments 17.456 17.051 12.375 21.992 32.25
Cash 17.456 17.051 12.375 21.992 32.25
Total Receivables, Net 2.255 2.144 2.205 4.174 5.927
Accounts Receivable - Trade, Net 1.795 1.709 2.111 4.134 5.897
Total Inventory 4.879 4.9 4.513 3.402 2.821
Prepaid Expenses 3.884 4.339 4.912 4.806 3.106
Other Current Assets, Total 9.92 0
Total Assets 52.906 53.265 59.255 69.539 68.713
Property/Plant/Equipment, Total - Net 1.757 1.734 1.7 1.751 0.674
Property/Plant/Equipment, Total - Gross 2.18 2.032 1.99 2.033 0.948
Accumulated Depreciation, Total -0.423 -0.298 -0.29 -0.282 -0.274
Intangibles, Net 22.229 22.651 23.072 23.494 23.916
Other Long Term Assets, Total 0.446 0.446 10.478 0 0.019
Total Current Liabilities 19.093 15.471 11.951 12.652 12.592
Accounts Payable 3.708 4.929 3.786 4.918 4.74
Accrued Expenses 8.494 7.357 6.381 6.582 6.409
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6.89 3.184 1.781 1.145 1.431
Other Current Liabilities, Total 0.001 0.001 0.003 0.007 0.012
Total Liabilities 44.861 41.654 37.703 37.754 36.822
Total Long Term Debt 24.783 25.022 24.926 24.195 24.23
Long Term Debt 24.783 25.022 24.926 24.195 24.23
Total Equity 8.045 11.611 21.552 31.785 31.891
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.008 0.005 0.005 0.014 0.013
Additional Paid-In Capital 245.517 231.1 226.728 224.76 210.786
Retained Earnings (Accumulated Deficit) -237.48 -219.494 -205.181 -192.989 -178.908
Total Liabilities & Shareholders’ Equity 52.906 53.265 59.255 69.539 68.713
Total Common Shares Outstanding 79.1948 50.4733 48.2117 47.8944 44.7563
Total Preferred Shares Outstanding 0 0 0 0 0
Other Liabilities, Total 0.921 0.919 0.826 0.907
Minority Interest 0.064 0.242
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -52.6 -33.809 -38.5394 -32.1461 -21.9686
Cash From Operating Activities -34.97 -15.278 -20.4568 -22.7308 -9.82494
Cash From Operating Activities 1.719 1.727 1.73708 1.319 0.58434
Non-Cash Items 13.644 20.271 17.0073 9.02132 20.6123
Cash Interest Paid 0.028 0.757 0.142 0.01934 0.23455
Changes in Working Capital 2.267 -3.467 -0.66177 -0.9251 4.12831
Cash From Investing Activities -0.006 -0.007 0 -0.00653 -1.55734
Capital Expenditures -0.006 -0.007 -0.00653 0
Other Investing Cash Flow Items, Total 0 0 -1.55734
Cash From Financing Activities 43.937 19.492 21.772 24.5457 10.6799
Financing Cash Flow Items -0.731 -1.008 -2.57481 -2.11755 0
Issuance (Retirement) of Stock, Net 35.615 7.756 24.4468 25.8797 10.302
Issuance (Retirement) of Debt, Net 9.053 12.744 -0.1 0.78349 0.37791
Net Change in Cash 8.961 4.207 1.31519 1.80832 -0.70241
Deferred Taxes 0 -13.1812
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -18.164 -52.6 -38.282 -26.09 -12.009
Cash From Operating Activities -7.695 -34.97 -26.047 -16.615 -6.708
Cash From Operating Activities 0.426 1.719 1.29 0.861 0.431
Non-Cash Items 7.583 13.644 10.601 7.609 4.695
Cash Interest Paid 0.011 0.028 0.021 0.008 0.006
Changes in Working Capital 2.46 2.267 0.344 1.005 0.175
Cash From Investing Activities -0.006 -10.484 -0.006 0
Capital Expenditures -0.006 -0.006 -0.006 0
Cash From Financing Activities 8.15 43.937 40.816 40.443 30.868
Financing Cash Flow Items -0.335 -0.731 -0.623 -0.268 -0.095
Issuance (Retirement) of Stock, Net 9.11 35.615 32.386 31.608 21.86
Issuance (Retirement) of Debt, Net -0.625 9.053 9.053 9.103 9.103
Net Change in Cash 0.405 8.961 4.285 23.822 24.16
Other Investing Cash Flow Items, Total -10.478
Foreign Exchange Effects -0.05

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Bio Therapeutic Drugs

200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,975.91 Price
-0.870% 1D Chg, %
Biaya inap posisi Long -0.0179%
Biaya inap posisi short 0.0097%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

BTC/USD

27,855.25 Price
-1.750% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

XRP/USD

0.43 Price
-3.580% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00334

Oil - Crude

69.28 Price
-0.320% 1D Chg, %
Biaya inap posisi Long -0.0194%
Biaya inap posisi short -0.0025%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda